60882-72-6 Usage
Uses
Used in Pharmaceutical Applications:
1H-Benzimidazole-1,2-diamine,5-methyl-(9CI) is used as a potential anti-cancer agent for its ability to inhibit kinases, which are enzymes that play a crucial role in cell growth and division. Its potential use in cancer treatment is currently under investigation.
Used in Research Applications:
In research, 1H-Benzimidazole-1,2-diamine,5-methyl-(9CI) is utilized for studying its biological activity and exploring its potential uses in various fields. Its unique properties as a 5-methyl derivative may offer specific advantages for certain applications.
Used in Anti-bacterial Applications:
1H-Benzimidazole-1,2-diamine,5-methyl-(9CI) has been investigated for its anti-bacterial properties, which could make it a valuable compound in the development of new antibiotics to combat resistant bacteria.
Used in Anti-fungal Applications:
Additionally, 1H-Benzimidazole-1,2-diamine,5-methyl-(9CI) has been studied for its anti-fungal properties, indicating its potential use in treating fungal infections and developing new anti-fungal medications.
Further research is ongoing to fully understand the potential uses and benefits of 1H-Benzimidazole-1,2-diamine,5-methyl-(9CI) in various fields, including pharmaceuticals, research, and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 60882-72-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,8,8 and 2 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 60882-72:
(7*6)+(6*0)+(5*8)+(4*8)+(3*2)+(2*7)+(1*2)=136
136 % 10 = 6
So 60882-72-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N4/c1-5-2-3-7-6(4-5)11-8(9)12(7)10/h2-4H,10H2,1H3,(H2,9,11)
60882-72-6Relevant articles and documents
Method of inhibiting the advanced glycosylation of proteins using 1,2-disubstituted-benzimidazoles
-
, (2008/06/13)
The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging). Accordingly, composition is disclosed which comprises 1,2-disubstituted benzimidazoles capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.
